IL205954A - Intermediate Material and Methods for Preparing Zarlonone Macrolides - Google Patents
Intermediate Material and Methods for Preparing Zarlonone MacrolidesInfo
- Publication number
- IL205954A IL205954A IL205954A IL20595410A IL205954A IL 205954 A IL205954 A IL 205954A IL 205954 A IL205954 A IL 205954A IL 20595410 A IL20595410 A IL 20595410A IL 205954 A IL205954 A IL 205954A
- Authority
- IL
- Israel
- Prior art keywords
- intermediates
- making
- methods
- zearalenone
- macrolide analogs
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 title 1
- MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1240907P | 2007-12-07 | 2007-12-07 | |
| US1241107P | 2007-12-07 | 2007-12-07 | |
| US1240807P | 2007-12-07 | 2007-12-07 | |
| US8004808P | 2008-07-11 | 2008-07-11 | |
| PCT/US2008/013498 WO2009075818A1 (en) | 2007-12-07 | 2008-12-08 | Intermediates and methods for making zearalenone macrolide analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL205954A0 IL205954A0 (en) | 2010-11-30 |
| IL205954A true IL205954A (en) | 2017-01-31 |
Family
ID=40445478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL205954A IL205954A (en) | 2007-12-07 | 2010-05-25 | Intermediate Material and Methods for Preparing Zarlonone Macrolides |
| IL205983A IL205983A (en) | 2007-12-07 | 2010-05-26 | Intermediates in the synthesis of Zaralnon macrolide analogs |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL205983A IL205983A (en) | 2007-12-07 | 2010-05-26 | Intermediates in the synthesis of Zaralnon macrolide analogs |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US8350059B2 (enExample) |
| EP (2) | EP2231634B1 (enExample) |
| JP (3) | JP5492786B2 (enExample) |
| CN (2) | CN101889005B (enExample) |
| BR (2) | BRPI0820953B1 (enExample) |
| CA (2) | CA2708143C (enExample) |
| IL (2) | IL205954A (enExample) |
| MX (2) | MX2010006091A (enExample) |
| RU (2) | RU2478630C2 (enExample) |
| WO (2) | WO2009075823A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ535101A (en) | 2002-03-08 | 2007-07-27 | Eisai Co Ltd | Macrocyclic compounds useful as pharmaceuticals |
| EP2182941B1 (en) | 2007-07-25 | 2018-02-28 | Eisai R&D Management Co., Ltd. | Multikinase inhibitors for use in the treatment of cancer |
| JP5492786B2 (ja) | 2007-12-07 | 2014-05-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゼラレノンマクロライドアナログを作製するための中間体および方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69666A (en) * | 1982-09-13 | 1987-10-20 | Lilly Co Eli | 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use |
| GB9225396D0 (en) | 1992-12-04 | 1993-01-27 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5795910A (en) | 1994-10-28 | 1998-08-18 | Cor Therapeutics, Inc. | Method and compositions for inhibiting protein kinases |
| SK286592B6 (sk) * | 1997-07-08 | 2009-01-07 | Bristol-Myers Squibb Company | Derivát epotilónu, farmaceutický prostriedok s jeho obsahom a jeho použitie |
| JP2004292315A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | Ｔａｋ１阻害剤 |
| JP2004292314A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
| NZ535101A (en) * | 2002-03-08 | 2007-07-27 | Eisai Co Ltd | Macrocyclic compounds useful as pharmaceuticals |
| US7915306B2 (en) | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| WO2008021213A1 (en) | 2006-08-11 | 2008-02-21 | Nicolas Winssinger | Macrocyclic compounds useful as inhibitors of kinases and hsp90 |
| WO2008149244A2 (en) * | 2007-06-05 | 2008-12-11 | Nicolas Winssinger | Compositions and methods comprising analogues of radicicol a |
| EP2182941B1 (en) | 2007-07-25 | 2018-02-28 | Eisai R&D Management Co., Ltd. | Multikinase inhibitors for use in the treatment of cancer |
| TW200924749A (en) * | 2007-07-25 | 2009-06-16 | Eisai R & Amp D Man Co Ltd | Zearalenone macrolide derivatives and uses of the same |
| JP5492786B2 (ja) | 2007-12-07 | 2014-05-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゼラレノンマクロライドアナログを作製するための中間体および方法 |
-
2008
- 2008-12-08 JP JP2010536950A patent/JP5492786B2/ja active Active
- 2008-12-08 EP EP08860344.4A patent/EP2231634B1/en active Active
- 2008-12-08 RU RU2010128103/04A patent/RU2478630C2/ru active
- 2008-12-08 WO PCT/US2008/013512 patent/WO2009075823A1/en not_active Ceased
- 2008-12-08 US US12/746,672 patent/US8350059B2/en active Active
- 2008-12-08 US US12/746,675 patent/US8507696B2/en active Active
- 2008-12-08 MX MX2010006091A patent/MX2010006091A/es active IP Right Grant
- 2008-12-08 WO PCT/US2008/013498 patent/WO2009075818A1/en not_active Ceased
- 2008-12-08 EP EP08860534.0A patent/EP2231635B1/en active Active
- 2008-12-08 CN CN200880119543.8A patent/CN101889005B/zh active Active
- 2008-12-08 BR BRPI0820953-7A patent/BRPI0820953B1/pt active IP Right Grant
- 2008-12-08 CA CA2708143A patent/CA2708143C/en active Active
- 2008-12-08 CN CN2008801195442A patent/CN101889006B/zh active Active
- 2008-12-08 CA CA2708141A patent/CA2708141C/en active Active
- 2008-12-08 BR BRPI0820958-8A patent/BRPI0820958B1/pt active IP Right Grant
- 2008-12-08 MX MX2010005999A patent/MX2010005999A/es active IP Right Grant
- 2008-12-08 JP JP2010536949A patent/JP5496908B2/ja active Active
- 2008-12-08 RU RU2010128096/04A patent/RU2497803C2/ru active
-
2010
- 2010-05-25 IL IL205954A patent/IL205954A/en active IP Right Grant
- 2010-05-26 IL IL205983A patent/IL205983A/en active IP Right Grant
-
2013
- 2013-01-03 US US13/733,562 patent/US20130211103A1/en not_active Abandoned
-
2014
- 2014-03-05 JP JP2014042331A patent/JP2014141498A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL195029A0 (en) | Polymorphs | |
| TWI348356B (en) | Smoking apparatus | |
| IL208410A0 (en) | Halichondrin b analogs | |
| PL1992876T3 (pl) | Aparat do spalania | |
| GB0720662D0 (en) | Combustion apparatus | |
| ZA200900387B (en) | Macrolide synthesis process | |
| ZA200806238B (en) | Expression system | |
| PL2001670T3 (pl) | Rurka do celów medycznych | |
| ZA201002297B (en) | Improved method for producing diesters | |
| GB0621234D0 (en) | Expression system | |
| EP2127145A4 (en) | MECHANISM FOR CHANNEL SYNCHRONIZATION | |
| EP2089975A4 (en) | METHOD FOR INTERLEAVING A SEQUENCE OF CONTINUOUS LENGTH | |
| GB2456929B (en) | Synchronization | |
| IL205954A0 (en) | Intermediates and methods for making zearalenone macrolide analogs | |
| EP2195319A4 (en) | POLYMORPHS OF VALOMACICLOVIR | |
| EP2197879A4 (en) | CAMPTOTHECIN ANALOGUES SUBSTITUTED IN C7 | |
| ZA200903609B (en) | Motilide polymorphs | |
| GB0721991D0 (en) | Preparation method | |
| EP2197279A4 (en) | C10-SUBSTITUTED CAMPTOTHECIN ANALOG | |
| SI2089408T1 (sl) | Postopek za sintezo makrolidov | |
| GB2437332B (en) | Tube | |
| IL197022A0 (en) | Novel preparation method | |
| GB0718748D0 (en) | Diagnostic method | |
| EP2088083A4 (en) | PACKING STRIP DEVICE | |
| GB0620344D0 (en) | Attachment apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |